|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1650 Diagonal Road |
Address2 |
|
| City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1386-12
|
||||||||
|
6. House ID# 321810000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Delaney O'Shea |
Date | 5/27/2022 10:40:32 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Coalition letter addressed to Senators Patty Murray and Richard Burr, urging the Senate to reauthorize the Early Hearing Detection and Intervention (EHDI) program.
Coalition letter addressed to CMS Administrator Chiquita Brooks-LaSure urging CMS not to disrupt team-based care in the facility setting and to revise the split or shared visit policy to allow the physician or QHP who is managing and overseeing the patients care to bill for the service.
Coalition letter addressed to HRSA Administrator Carole Johnson asking that HRSA reopen the Period 1 reporting window for Provider Relief Funding for at least 60 days and engage in a targeted campaign to reach those who have yet to comply.
Coalition letter addressed to Senators Kaine and Young and Representatives Wild and McKinley thanking them for introducing the Dr. Lorna Breen Health Care Provider Protection Act (S. 610/H.R. 1667).
Coalition letter addressed to FDA Commissioner Robert Califf asking the FDA to work with stakeholders in educating consumers to consult with their health care providers to determine whether OTC hearing devices will be a quality option for them.
Coalition letter requesting information from Dr. Micky Tripathi regarding electronic prior authorization standards, implementation specifications, and certification criteria. Specifically, the letter requests that ONC and CMS adopt the electric prior authorization process.
Coalition letter addressed to CMS Director Dr. Meena Seshamani requesting that MA plans follow a standardized process for all medical record requests using a secure online portal. In addition, the letter requests the CMS establish a stars measure that would aware points to MA plans that maintain an adequate network of specialty physicians, including those that participate in the QPP.
A coalition letter addressed to Chairs and Ranking Members of the Senate Finance Committee, House Ways and Means Committee, and House Energy and Commerce Committee requesting that the committees collaborate with the provider community to immediately initiate formal proceedings (hearing, roundtables, expert panels, etc.) to discuss potential reforms to the Medicare physician payment system to ensure continued beneficiary access to care.
Issues pertaining to the scope of practice legislation, in general.
Issues pertaining to Medicare physician reimbursement, in general.
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to the Early Detection and Intervention Program, in general.
Issues pertaining to COVID-19, in general.
Issues pertaining to healthcare liability reform, in general.
Issues pertaining to healthcare practice and the Federal Supremacy Clause at the Department of Veterans Affairs, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in Build Back Better Legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Coalition letter addressed to CMS Administrator Chiquita Brooks-LaSure urging CMS not to disrupt team-based care in the facility setting and to revise the split or shared visit policy to allow the physician or QHP who is managing and overseeing the patients care to bill for the service.
Coalition letter addressed to Chairs and Ranking Members of the Senate Finance Committee, House Ways and Means Committee, and House Energy and Commerce Committee urging them to hold hearings on the future of the Medicare physician fee schedule and the status of other policies included in the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), including the Quality Payment Program.
Coalition letter addressed to HRSA Administrator Carole Johnson asking that HRSA reopen the Period 1 reporting window for Provider Relief Funding for at least 60 days and engage in a targeted campaign to reach those who have yet to comply.
Coalition letter addressed to Senators Kaine and Young and Representatives Wild and McKinley thanking them for introducing the Dr. Lorna Breen Health Care Provider Protection Act (S. 610/H.R. 1667).
Coalition letter addressed to CMS Director Dr. Meena Seshamani requesting that MA plans follow a standardized process for all medical record requests using a secure online portal. In addition, the letter requests the CMS establish a stars measure that would aware points to MA plans that maintain an adequate network of specialty physicians, including those that participate in the QPP.
Issues pertaining to the scope of practice legislation, in general.
Issues pertaining to Medicare physician reimbursement, in general
Issues related to hearing healthcare, in general.
Issues pertaining to health information technology and electronic health records, in general.
Issues pertaining to the Early Detection and Intervention Program, in general.
Issues pertaining to Graduate Medical Education, in general.
Issues pertaining to COVID-19, in general.
Issues related to the potential expansion of Medicare to cover hearing health benefits in Build Back Better Legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Stewart |
|
|
|
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Coalition letter addressed to Senate Majority Leader Chuck Schumer, Senate Minority Leader Mitch McConnell, House Speaker Nancy Pelosi, and House Minority Leader Kevin McCarthy urging Congress to respond to a new and growing threat to our nations youth, e-cigarette manufacturers use of synthetic nicotine to evade Food and Drug Administration (FDA) oversight.
Issues pertaining to tobacco control, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Thomas |
Radder |
|
|
|
Christopher |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |